Minimus Spine, Inc. (www.minimusspine.com) announced today that it has successfully closed on $520k in angel financing to pursue regulatory certification of its patented system for spinal injections, known as TrioJection. “We believe patients need a safe and effective non-surgical treatment for a painful herniated disc and the literature supporting intradiscal ozone injection continues to grow. Recent peer-reviewed papers by Lenhert and Chen further confirm that ozone consistently shrinks a herniated disc and may be capable of reducing inflammation,” said David Hooper, PhD, Minimus Spine’s Founder and CEO. He continued, “The investors in this round include spine surgeons, pain management physicians, experienced medical device executives and professional investors. Its a broad base of support because investors appreciate the existing literature and the opportunity to lower the cost of spine care and improve patient outcomes. With steroid injections coming under greater scrutiny, prompted by recent reports of fungal meningitis contamination, patients and physicians will increasingly look for alternatives. I am also pleased to announce Wes Johnson’s appointment to our Board of Directors. Wes is a veteran of the spine industry and shares the Minimus vision of bringing this treatment to the U.S.” Wes Johnson added, “I am especially excited by the potential of Minimus Spine’s TrioJection system because financially strained healthcare systems, in the US and around the world, will highly value its combination of being cost-effective and non-surgical.”
About Minimus Spine: Established in 2006, Minimus Spine is a privately held medical device company dedicated to developing its ozone technology for medical applications. The company is focused on the treatment of spinal disorders related to herniated discs. Minimus Spine is headquartered in Austin, TX. For more information on Minimus Spine, please visithttp://www.minimusspine.com
Minimus Spine ™ Attracts Over $500k in Angel Financing to Advance its TrioJection System to Treat Disc Herniation with an Injection of Ozone. Wes Johnson Appointed to Board of Directors
(Visited 2 times, 1 visits today)